141 related articles for article (PubMed ID: 19498273)
1. Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice.
Kimura S; Kontani H
J Pharmacol Sci; 2009 Jun; 110(2):213-7. PubMed ID: 19498273
[TBL] [Abstract][Full Text] [Related]
2. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
Chen SR; Khan GM; Pan HL
Anesthesiology; 2001 Oct; 95(4):1007-12. PubMed ID: 11605898
[TBL] [Abstract][Full Text] [Related]
3. Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation.
Takeda K; Sawamura S; Tamai H; Sekiyama H; Hanaoka K
Anesthesiology; 2005 Oct; 103(4):837-44. PubMed ID: 16192777
[TBL] [Abstract][Full Text] [Related]
4. A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice.
Hofer M; Pospíšil M; Dušek L; Hoferová Z; Weiterová L
Radiat Res; 2011 Aug; 176(2):269-72. PubMed ID: 21663397
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism and effect of cyclooxygenase-2 inhibitor meloxicam on the protection of diabetic nephropathy in rats].
Liu ZC; Zhou QL; Ouyang C; Deng SL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):635-8. PubMed ID: 16114545
[TBL] [Abstract][Full Text] [Related]
6. Systemic meloxicam reduces tactile allodynia development after L5 single spinal nerve injury in rats.
Takahashi M; Kawaguchi M; Shimada K; Nakashima T; Furuya H
Reg Anesth Pain Med; 2005; 30(4):351-5. PubMed ID: 16032587
[TBL] [Abstract][Full Text] [Related]
7. Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial.
Gruet P; Seewald W; King JN
BMC Vet Res; 2013 May; 9():92. PubMed ID: 23638669
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice.
Santos AR; Vedana EM; De Freitas GA
Inflamm Res; 1998 Jul; 47(7):302-7. PubMed ID: 9719494
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effect of combined administration of inducible nitric oxide synthase inhibitor with cyclooxygenase-2 inhibitors in neuropathic pain in rats.
Dudhgaonkar SP; Tandan SK; Kumar D; Naik AK; Raviprakash V
Eur J Pain; 2007 Jul; 11(5):528-34. PubMed ID: 16920373
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
Bach-Rojecky L; Salković-Petrisić M; Lacković Z
Eur J Pharmacol; 2010 May; 633(1-3):10-4. PubMed ID: 20123097
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive Interactions Between Meloxicam and Gabapentin in Neuropathic Pain Depend on the Ratio used in Combination in Rats.
Espinosa-Juárez JV; Jaramillo-Morales OA; Corona-Ramos JN; Medina-López JR; López-Muñoz FJ
Drug Dev Res; 2016 May; 77(3):134-42. PubMed ID: 27041220
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits.
Tsailas PG; Babis GC; Nikolopoulos K; Soucacos PN; Korres DS
J Surg Res; 2009 Jan; 151(1):108-14. PubMed ID: 18656899
[TBL] [Abstract][Full Text] [Related]
14. Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system.
Montejo C; Barcia E; Negro S; Fernández-Carballido A
Int J Pharm; 2010 Mar; 387(1-2):223-9. PubMed ID: 19963049
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin.
Martin AI; Nieto-Bona MP; Castillero E; Fernandez-Galaz C; Lopez-Menduina M; Gomez-Sanmiguel AB; Gomez-Moreira C; Villanua MA; Lopez-Calderon A
J Physiol Pharmacol; 2012 Dec; 63(6):649-59. PubMed ID: 23388481
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
Honma S; Takahashi N; Shinohara M; Nakamura K; Mitazaki S; Abe S; Yoshida M
Eur J Pharmacol; 2013 Sep; 715(1-3):181-8. PubMed ID: 23747596
[TBL] [Abstract][Full Text] [Related]
18. Agonist of the adenosine A3 receptor, IB-MECA, and inhibitor of cyclooxygenase-2, meloxicam, given alone or in a combination early after total body irradiation enhance survival of γ-irradiated mice.
Hofer M; Pospíšil M; Dušek L; Hoferová Z; Komůrková D
Radiat Environ Biophys; 2014 Mar; 53(1):211-5. PubMed ID: 24263216
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of meloxicam on aluminum overload-induced cerebral damage in mice.
Jun-Qing Y; Bei-Zhong L; Bai-Cheng H; Qi-Qin Z
Eur J Pharmacol; 2006 Oct; 547(1-3):52-8. PubMed ID: 16928369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
